STUDY SEARCH RESULTS

1 study found for your search request:  3475-01A

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chem...
Condition: Carcinoma, Non-Small-Cell Lung
Minimum Age: 18 years, Maximum Age: N/A
Gender: All
Study ID: NCT04165070
Status: Recruiting
Has Enrolling Locations in US or Canada




Copyright © 2025 · Merck & Co., Inc., Rahway, NJ, USA, and its affiliates. All rights reserved. · This site is intended only for residents of the United States.
Cookie Preferences  Privacy  Terms of Use  Consumer Health Data Privacy Policy  Your Privacy Choices   Accessibility  U.S. Corporate Site